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El estrés oxidativo en la preeclampsia, más que las enzimas
Preeclampsia is a disease characterized by increased blood 
pressure (blood pressure (BP) > 140 mmHg), proteinuria 
(300 mg/L/day) and edema, that occurs regularly after the 
twentieth week of gestation. There are risk factors such as 
chronic hypertension, diabetes mellitus and obesity to the 
development of this disease. Preeclampsia is pregnancy-
specific, affecting 2% to 7% of women, and is a leading 
cause of perinatal and maternal morbidity and mortality. 
Preeclampsia has been associated with growth retarda-
tion, low birth weight and premature birth, mothers may 
have placental abruption, renal failure, cerebral hemor-
rhage, disseminated intravascular coagulation and circula-
tory collapse.1-3
Clinical features
Clinically, two types of preeclampsia have been estab-
lished: 1) mild preeclampsia: when the patient is 140 mm 
Hg < BP <160 mmHg, 300 mg/L < proteinuria < 2 g/L, 
or its equivalent strip, 2) severe preeclampsia: when the 
patient has BP > 160 mmHg at rest on two occasions with 
a difference between measures of 6 h and proteinuria > 
2g/L/day, or 3(+) to 4(+) by dipstick of a random sample, 
oliguria, edema 2(+) and / or cerebral or visual disturbanc-
es, epigastric pain, pulmonary edema, cyanosis, impaired 
liver function and thrombocytopenia.
Pathophysiology
The pathogenesis of preeclampsia is still not completely 
understood due to multiple factors surrounding the on-
set of the disease, although it has been considered the 
hypothesis that endothelial dysfunction is a vital point, 
because changes in the structure of maternal vascular en-
dothelial function generates multisystem damage. In an 
initial attempt the pathogenesis of preeclampsia has been 
divided into two stages: alterations of placental perfusion 
and maternal syndrome. Alteration of placental perfusion 
is associated with a failure of trophoblast invasion by me-
chanical factors, biochemical and / or immunological. In 
case of preeclampsia the invasion is deficient which fa-
vors fibrin and thrombosis, triggering atherosclerosis by 
modifying the size of normal veins, followed by ischemia 
and poor placental perfusion. Moreover, the maternal syn-
drome is characterized by higher BP and impaired renal 
function, there is vasospasm decreasing perfusion to all 
organs by the presence of pressor agents and activation 
of platelets (Fig. 1).
In women with preeclampsia it has been observed an in-
crease in certain cytokines such as tumor necrosis factor 
alpha (TNF-a), an inducer of hypoxia-stimulated endothe-
lial dysfunction. Cytokines activate neutrophils that gen-
erate oxidative insult. During placental development in 
women with preeclampsia there is a deficient signaling of 
Figure 1. Placental implantation process
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epidermal growth factor in combination with heparin (HB-
EGF), responsible for trophoblast invasion, thus amend-
ing the trophoblast survival, differentiation and invasion, 
causing poor placental perfusion and hypertension. An-
other factor that influences the endothelial dysfunction 
is the alteration of production and disposal of nitric oxide 
(NO•) leading to increased peripheral resistance, BP and
sensitivity to vasopressors.
It has also been shown that in the plasma of preeclamp-
tic women the nuclear factor factor-kappa B (NF-κB) be-
comes active initiating a systemic inflammatory process by 
promoting the synthesis of cytokines (monocyte chemot-
actic protein (MCP), interleukin (IL)-6 and 8) and the ex-
pression of intracellular adhesion molecule-1 (ICAM-1), 
which maintains the systemic inflammatory process (Fig. 
2). These same mechanisms are involved in the genesis of 
atherosclerosis, also seen in the spiral arteries of women 
with preeclampsia.
Obesity and preeclampsia
Obesity is associated with chronic activation of inflam-
matory pathways in both adipocytes and in macrophages 
residing in or infiltrating the adipose tissue.4 The possible 
ligation of Toll-like receptors on adipocytes or macrophag-
es by dietary lipids could exploit the canonical inflamma-
tory signaling pathway to activate NF-kB and produce in-
flammatory mediators.
Oxidative stress
2.1. Free radicals
A free radical is a molecule or atom with one or more un-
paired electrons in its outermost orbital, making it highly 
reactive and unstable, causing a chain reaction that dam-
ages cells and tissues.5 Oxidative stress is defined as the 
biochemical imbalance by excessive production of free 
radicals that can not be controlled by the antioxidant sys-
tems. The damage occurs due to free radical generating 
covalent links among proteins, unsaturated fatty acids of 
biological membranes, carbohydrates and nucleic acids, 
inducing conditions such as diabetes, atherosclerosis, in-
flammation, ischemia / reperfusion, among others.6;7
The oxygen-derived free radicals superoxide anion (O2-) and 
hydroxyl radical (OH•) are grouped under the term Reactive
Oxigen Species (ROS) and stand out above others both by 
their abundance and their damage to biological systems. 
The hydrogen peroxide (H2O2) is not a free radical, but falls 
into the category of ROS because it is decomposed in the 
presence of transition metals (mainly Fe 2+) to produce OH•.
Also, nitrogen is also capable of forming free radicals such 
as two oxides: the radical NO• and nitrogen dioxide radi-
cal (NO2•), forming the so-called reactive nitrogen species
(RNS). In turn, the radicals O2• - and NO• react together to
form peroxynitrite anion (ONOO-), among others.7
2.2. Nuclear factor Kappa-B (NF-κB)
Oxidative stress is a potent inducer of placental synthesis 
and release of proinflammatory factors. Most of these ef-
fects are mediated through the p38 mitogen-activated 
protein kinase (MAPK) and NF-κB pathways.8;9 NF-κB 
signaling pathway is a complex network that regulates 
a cellular pathway involved in a myriad of physiological 
and pathological scenarios. There are at least two well-
characterized signaling pathways leading to NF-κB ac-
tivation, classical and alternative, and both rely on the 
catalytic activity of known IκB kinases (IKKs). The clas-
sical NF-κB signaling pathway is typically triggered by a 
vast number of proinflammatory cytokines, viruses, and 
bacteria, and hence, it leads to a coordinate inflamma-
tory/immune response culminating in the expression of 
multiple cytokines, chemokines, adhesion molecules, 
and proinflammatory proteolytic enzymes. Alternative 
NF-κB signaling pathway is normally triggered by non-
proinflammatory cytokines (e.g., lymphotoxin β (LTβ), B-
cell activating factor (BAFF), and CD40 ligand (CD40L)) 
as well as some viruses (e.g., human T-cell leukemia virus 
(HTLV) and Epstein-Barr virus (EBV)).10;11
NF-κB signaling pathway is regulated by IΚB family. Most 
stimuli activate NF-κB through IΚB kinase-dependent 
(IKK-dependent) phosphorylation, polyubiquitination and 
subsequent proteasomal degradation of IΚB proteins. The 
liberation of NF-κB allows translocation of heterodimer to 
the nucleus, where it can regulate the expression of spe-
cific genes typically involved in immune and inflammatory 
responses and in cell growth control.12 Inducible genes 
that are known to be transactivated by NF-κB include, but 
are not limited to, IL-1β, IL-6, IL-8, TNF-a, interferon gam-
ma (IFNγ), MCP-1, inducible nitric oxide synthase (iNOS), 
cyclooxygenase-2 (COX-2), ICAM-1, and vascular cell ad-
hesion molecule-1 (VCAM-1).4
By microarray studies it has been showed that in placenta 
of preeclamptic women there are increased expression of 
genes related to chemotaxis and the NF-κB pathway and 
decreased expression of genes related to antigen process-
Figure 2. Mechanisms involved in the development of hypertension 
of preeclampsia
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ing and presentation, such as human leukocyte antigen 
B.13 Although enhanced apoptosis is well known in pla-
centas with preeclampsia, the role of transcription factor 
NF-κB in the process is still being debated. Increased troph-
oblastic apoptosis is at least partially induced by NF-κB.14
Glucocorticoid receptors can modulate NF-κB activity in 
the nucleus by regulating several key events including 
NF-κB DNA binding. Furthermore, glucocorticoids may 
serve as inhibitors of NF-κB activity via their ability to 
modulate the activity of proteins involved in the MAPK 
pathways including c-jun N-terminal kinase (JNK), p38, 
and MAP kinase phosphatase-1 (MKP-1), all of which 
can crosstalk and modulate NF-κB activity, and thus, in-
flammatory responses. 15-17
Administration of vitamins C and E blocks activation of 
the p38 and stress-activated protein kinase MAPK and 
NF-κB pathways. Vitamin administration or p38 pathway 
inhibition also reduced COX-2 expression, TNF-a and IL-1β
secretion, and the levels of apoptosis. 
Preeclampsia, oxidative stress and antioxidant systems
Pregnancy increases oxidative stress, a condition that 
can be aggravated with preeclampsia, because free radi-
cals are detrimental to the integrity of the endothelium, 
causing maternal vascular dysfunction. According to this 
knowledge, preeclampsia is a condition where there is an 
imbalance between the endogenous antioxidant system 
and free radicals, mostly ROS. These species are caused 
by: mitochondrial aerobic metabolism, activation of NA-
DPH oxidase, xanthine oxidase (XO), cytochrome P450 
and lipid peroxidation process (Fig. 3).18
To stop the action of oxidizing agents or free radicals, the 
body has endogenous antioxidant mechanisms which are 
responsible for the degradation of those products, these 
may be enzymatic (superoxide dismutase (SOD), catalase 
(CAT), glutathione peroxidase (GPx) and glutathione re-
ductase (GR)) and nonenzymatic (vitamin E, C, carotene, 
glutathione) (Fig. 4).7;19 Under physiological conditions, 
these defense mechanisms maintain a low concentration 
of ROS in the cell and its activity is regulated, hence the 
balance between ROS production and antioxidant defens-
es determines the degree of oxidative stress.
Implications of oxidative stress 
The ROS play an important role in the pathogenesis of 
premature delivery, fetal growth restriction, preeclampsia, 
eclampsia, hemorrhage and cerebral edema, cortical blind-
ness, retinal edema and blindness, renal tubular necrosis, 
pulmonary edema and laryngeal edema, HELLP syndrome 
and hepatic rupture, placental infarction and placental 
abruption, maternal infections and maternal malnutrition.20
SOD
SOD is the first antioxidant and is responsible for breaking 
two molecules of O2- to H2O2, which in turn CAT of perox-
isomes makes molecular O2 and water. The SOD contains 
metal ions with redox activity in its catalytic center and 
there are three isoforms: 1) CuZn-SOD, cytosolic, 2) Mn-
SOD, specifically in the mitochondria and 3) extracellular-
SOD, secreted by many cells, including placental cells.21
Deficiency in SOD activity in the placenta may increase the 
production of O2- and the generation of lipid, protein and 
DNAoxidation. The SOD and NO• compete for O2-, SOD 
deficiency causes increased O2- and the interactions of 
the NO•, reducing vasodilation and resulting in the gen-
eration of ONOO- which subsequently leads to tyrosine 
nitrosylation protein. It also starts a chain reaction which 
affects polyunsaturated fatty acids due to the loss of H+, 
forming hydroperoxides and other free radicals, causing 
damage to the endothelium. In addition, SOD modulates 
differentiation of trophoblast and its decrease leads to a 
greater sincitialisation that leads to apoptosis and increas-
es the volume of trophoblast.22
Figure 3. Mechanisms that trigger the increase in leukocyte 
adhesion in preeclampsia
ICAM-1: intracellular adhesion molecule-1, IL-6: interleukin-6, IL-8: interleukin-8, MCP-
1: monocyte chemotactic protein-1, NF-κB: nuclear factor Kappa-B, ROS: reactive oxi-
gen species
Figure 4. Intracellular formation of reactive oxigen species
CAT: catalase, GPx: glutathione peroxidase, NOS: nitric oxide synthase, NO2•: nitrogen
dioxide radical, NO2•: nitrogen trioxide radical, OH•: hydroxyl radical, ONOO-: peroxyni-
trite anion, SOD: superoxide dismutase
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GPx
The glutathione system comprises four major components, 
three enzymes: GPx, GR and glutathione-S-transferase 
(GST) and a non-enzymatic, reduced glutathione (GSH). 
There are five different types of GPx containing selenocyst-
eine in its active site. GPx4, GPx1 and cytosolic enzymes 
are abundant in many tissues, GPx2 expressed in the gas-
trointestinal tract, GPx3 in the liver (form found primarily in 
the bloodstream) and GPx5, not selenium (Se) dependent, 
is specifically expressed in the epididymis. All of these iso-
enzymes reduce H2O2 and alkyl hydroperoxides, however, 
their specificity for the substrates can be different.23
Research has shown that the human placenta produces 
and secretes GPx3 and plasma levels increase during preg-
nancy, but other researchers report GPx levels unchanged 
or decreased in plasma and erythrocytes near the end 
of pregnancy. GPx levels in erythrocytes and plasma are 
highly sensitive to Se intake and this element is widely 
used for monitoring this enzyme. The decreased activity 
of GPx during preeclampsia contributes to oxidative stress 
and increased biological oxidation.23 Reduced GPx could 
be associated with increased generation of toxic lipid per-
oxides contributing to the endothelial dysfunction and hy-
pertension of preeclampsia.24
Prevention and treatment of preeclampsia 
Clinical data (vasospasm, headache, blurred vision, epi-
gastric pain, nausea and vomiting, diuresis), biophysical 
parameters (heart rate, blood pressure) and biochemical 
tests (proteinuria, blood count, platelet count, prothrom-
bin time, partial thromboplastin time, urea, creatinine, uric 
acid, albumin, bilirubin, ALT, AST, LDH) allow the prediction 
or early detection preeclampsia, but have a low sensitivity 
and predictive value. Thus, preventive studies have focused 
on demographic, family, medical and obstetric complica-
tions associated with an increased risk of preeclampsia.25;26
Some methods have been developed to prevent and treat 
preeclampsia: a) dietary manipulations: low-salt diet, fish oil 
supplements, calcium supplements, b) magnesium sulfate: 
to prevent seizures and reduce the recurrence of seizures, 
c) cardiovascular drugs: diuretics, antihypertensive drugs, d) 
tocopherol (vitamin E) and ascorbic acid (vitamin C) and e) 
antithrombotics: low doses of aspirin (ASA), ASA / dipyrida-
mole, ASA + heparin, ASA + ketanserin. Despite all these 
efforts, interruption of pregnancy is the definitive treatment. 
reeclampsia is a hypertensive disorder of 
pregnancy in which enzymatic antioxidant 
defenses fail and tissues are injured. Antiox-
idant enzyme activity (SOD, GPx) is significantly decreased, 
while lipoperoxidation is increased in preeclamptic groups 
compared to normal pregnant women.27 Beyond the en-
zymatic behavior, the NF-kB pathway unites the inflamma-
tory and metabolic responses and, represents a common 
point for better understanding pregnancy and its predis-
position to preeclampsia, also represents an alternative to 
develop new drugs to control this obstetric complication.
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